Scholars Central

Conference abstractPublished 2 Nov 2015

Nanoparticles with novel methodology to treat infectious diseases

Authors: Prabagaran Narayanasamy

University of Nebraska Medical Center, USA

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

The two major and important infectious diseases, human immunodeficiency virus (HIV) and Mycobacterium tuberculosis (TB) are responsible for maximum mortality. Therefore, improvements in drug and easy treatment regimens are needed immediately for treating both the infections. One of the important host cells infected by both HIV and TB is the mononuclear phagocyte (macrophage). We hypothesized and manufactured nanoformulations of antibiotics, antiretroviral therapy and gallium (Ga) targeting macrophage. The synthesized Ga nanoparticles inhibited growth of both HIV and mycobacterium in the macrophage separately and while coinfected for up to 15 days following single drug loading. The subcellular trafficking of Ga-NP was determined using known procedure and the presence of NP in all the compartments confirmed the multi-targeting approach. In addition, Gram-negative bacteria are the real cause of many potentially lethal infections, including pneumonia, wound or surgical site infections, sepsis, intra-abdominal infections, urinary tract infections, and meningitis. Novel Ceft-A and Cefep-A, drugs was synthesized, along with their respective nanoparticles. Ceft-A and Ceft-NP was observed to be better than Ceft against resistant Gram-negative bacteria. Also, Ceft-NP was able to reduce the bacterial growth of K. pneumoniae ATCC BAA-1705 and E. coli ATCC 35218 by 75% up to 10 days of infection. Thus, the novel antibiotic compounds, nanoparticles and macrophage routed drug delivery would be an excellent approach to target infectious diseases.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Medicinal Chemistry.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalMedicinal Chemistry
  • SubjectChemistry
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Prabagaran Narayanasamy”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels